Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axis

T Xiao, D Gao, X Gu, Y Zhang, Y Zhu, Z Zhang… - European Journal of …, 2023 - Elsevier
Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease characterized by
myofibroblast proliferation and extracellular matrix deposition that has a high mortality rate …
被引用次数：1 相关文章

Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axis

T Xiao, D Gao, X Gu, Y Zhang, Y Zhu… - European journal of … - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease characterized by
myofibroblast proliferation and extracellular matrix deposition that has a high mortality rate …

Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axis.

T Xiao, D Gao, X Gu, Y Zhang, Y Zhu… - European Journal of …, 2023 - europepmc.org
Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease characterized by
myofibroblast proliferation and extracellular matrix deposition that has a high mortality rate …